천식 치료의 단계적 접근법 Update

Stepwise Approach Update to the Asthma Treatment

  • 남영희 (동아대학교 의과대학 내과학교실) ;
  • 이수걸 (동아대학교 의과대학 내과학교실)
  • Nam, Young-Hee (Department of Internal Medicine, Dong-A University College of Medicine) ;
  • Lee, Soo-Keol (Department of Internal Medicine, Dong-A University College of Medicine)
  • 발행 : 2011.02.01

초록

Asthma is a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role. Chronic inflammation is associated with airway hyper-responsiveness, which leads to various airway symptoms. Approaches to asthma treatment have been changing because our knowledge about the pathogenesis and treatment of asthma is continually evolving. Until recently, the stepwise approach to the treatment of asthma was based on a patient' asthma severity. However, new international guidelines have recommended that treatment should be adjusted in a continuous cycle driven by the patient' asthma-control status. If asthma is not controlled on the current treatment regimen, treatment should be stepped up until control is achieved. When control is maintained for at least 3 months, treatment can be stepped down. Ongoing monitoring is essential to maintain control and to establish the lowest step and dose of treatment to minimize cost and maximize safety. However, the stepwise approach and recommended treatments are meant to assist, not replace, the clinical decision making necessary to determine the most appropriate treatment to meet the individual patient' needs and circumstances. This article is a review of the stepwise approach to the treatment of asthma recommended by the Global Initiative for Asthma 2009 and Expert Panel Report 3 of National Heart, Lung, and Blood Institute 2007.

키워드

참고문헌

  1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 2004;59:469-478. https://doi.org/10.1111/j.1398-9995.2004.00526.x
  2. Beasley R. The global burden of asthma report, global initiative for asthma (GINA) 2004. Available from: http://www.ginasthma.org.
  3. 이혜란, 홍동선, 손근찬. 소아 알레르기에 관한 조사. 대한의학협회지 1983;26:254-262.
  4. 신태순, 이금자, 윤혜선. 국민학교 아동에서의 알레르기 질환에 관한 조사. 알레르기 1990;10:201-212.
  5. Kim YK, Kim SH, Tak YJ, et al. High prevalence of current asthma and active smoking effect among the elderly. Clin Exp Allergy 2002;32:1706-1712. https://doi.org/10.1046/j.1365-2222.2002.01524.x
  6. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy 2000;30(Suppl 1):S2-S5. https://doi.org/10.1046/j.1365-2222.2000.00088.x
  7. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8:218-230. https://doi.org/10.1038/nri2262
  8. Global Strategy for Asthma Management and Prevention. Global initiative for asthma (GINA) report 2009. Available from: http://www.ginasthma.org.
  9. National Heart Lung and Blood Institute. National asthma education and prevention program: expert panel Report 3 (EPR-3): guideline for the diagnosis and management of asthma 2007. Available from: http://www.nhlbi.nih.gov/guidelines/asthma.
  10. 대한의학회, 보건복지가족부. 2007년 한국 성인 천식의 치료 지침. Available from: http://www.allergy.or.kr
  11. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129-136. https://doi.org/10.1164/rccm.200407-884OC
  12. Rabe KF, Pizzichini E, Stallberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006;129:246-256. https://doi.org/10.1378/chest.129.2.246